Studies have demonstrated the effectiveness of anti-TNF-α therapies in treating connective tissue diseases (CTD) (156), particularly SLE and cutaneous lupus erythematosus (CLE) (157). The gene discussed is TNF; the disease is systemic lupus erythematosus.